| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |